Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Oncology|October 14, 2015
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomasHiroshi Katagiri, Kentaro Nakayama, Sultana Razia, et al.
Molecular and Clinical Oncology|August 14, 2018
Ultrasound-guided intranodal lymphangiography with lipiodol for treatment of chylous ascites following surgery for ovarian cancer: A case reportKohei Nakamura, Kentaro Nakayama, Toshiko Minamoto, et al.
Cancer Science|July 30, 2022
Recommendations related to the analytical equivalence assessment of gene panel testingSumimasa Nagai, Hiroshi Nishihara, Takayoshi Suzuki, et al.
Oncotarget|March 31, 2018
Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patientsMasako Ishikawa, Kentaro Nakayama, Kohei Nakamura, et al.
Archives of Gynecology and Obstetrics|May 22, 2020
High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinomaMasako Ishikawa, Kentaro Nakayama, Kohei Nakamura, et al.
Oncology Letters|June 11, 2017
Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancerKentaro Nakayama, Munmun Rahman, Mohammed Tanjimur Rahman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 2016
High pretreatment plasma D-dimer levels are related to shorter overall survival in endometrial carcinomaKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.
Anticancer Research|June 9, 2016
High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical CarcinomaKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.
International Journal of Molecular Sciences|April 30, 2016
KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor RegionsKohei Nakamura, Kentaro Nakayama, Tomoka Ishibashi, et al.
British Journal of Cancer|February 11, 2025
Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancerYujin Kato, Ryo Seishima, Kaoru Hattori, et al.
Pageof 18